GameStop sees surge amid retail investor interest post Roaring Kitty's return. Dive into the frenzy that shook Wall Street in 2021. Learn about the meme stock craze and its impact on hedge funds and trading platforms.
Intel reportedly edges closer to a groundbreaking deal with Apollo Global Management for an $11 billion investment in a new chip plant in Ireland. Exclusive negotiations signal imminent progress, marking a strategic move by CEO Pat Gelsinger to expand Intel's footprint amidst surging chip demand.
No limit to number of fragments included in the poolsOptimized chemistry enables direct synthesis of up to 500 bp double stranded fragmentsTwist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to
IN8bio (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, presented in an oral session details about its robust and reproducible proprietary clinical-scale
12-month duration of response data from ENVISION study of UGN-102 to be discussed during company sponsored virtual event on June 13, 2024ENVISION data expected to support completion of UGN-102 NDA in Q3 2024Post-hoc
Brussels gears up to confront Microsoft's dominance in videoconferencing with fresh antitrust charges over Teams. Despite recent proposals, EU regulators remain unconvinced, fearing market manipulation and unfair competition. The impending charges signal an end to a decade-long truce, escalating tensions between tech giants and EU regulators.
Eight of nine experts expressed feeling "extremely confident" about prescribing ZORYVE foam to patients of diverse skin and hair types, including individuals with previous hair treatments, based on review of formulation
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system